Table 3. Selected PK Profile of Compounds 9a, 16a, and HSD-621.
iva |
poa |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
compd | species | Cl (mL/min/kg) | Vss (L/kg) | AUC (h ng/mL) | t1/2 (h) | Cmax (ng/mL) | tmax (h) | AUC (h ng/mL) | t1/2 (h) | F (%) |
9a | mouseb | 9.0 | 5.8 | 3588 | 9.5 | 449 | 0.5 | 3403 | 6.0 | 19 |
16a | mouseb | 5.4 | 1.8 | 6131 | 4.2 | 1554 | 2.0 | 14005 | 2.8 | 46 |
HSD-621 | mouseb | 9.0 | 4.2 | 3600 | 6.1 | 987 | 2.0 | 11700 | 4.8 | 67 |
HSD-621 | ratc | 8.0 | 3.8 | 4310 | 8.6 | 656 | 1.8 | 6542 | 3.3 | 61 |
HSD-621 | dogd | 1.0 | 1.8 | 32358 | 20.3 | 1444 | 2.8 | 43488 | 17.2 | 54 |
See the Experimental Procedures for dosing and analytical protocols.
C57B6 mice: iv dosed at 2 mg/kg in 50% DMSO/50% PEG200 and po dosed at 10 mg/kg in 2% Tween/0.5% methyl cellulose in water.
SD rat: iv dosed at 2 mg/kg in 50% DMSO/50% PEG200 and po dosed at 10 mg/kg in 2% Tween/0.5% methyl cellulose in water.
Male dog: iv dosed at 2 mg/kg in 50% DMSO/50% PEG200 and po dosed at 5 mg/kg in 2% Tween/0.5% methyl cellulose in water.